Celltrion to invest up to $478 mln to expand US factory in response to tariffs

South Korean pharmaceutical company Celltrion said on Wednesday that it plans to invest up to 700 billion Korean won ($478.17 million) to expand capacity at its U.S. factory in response to U.S. tariffs and rising demand. ...